Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Crohn's disease: Is there a place for neurological screening?
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4(+)CD25(hi) T Cells of Type 1 Diabetic and Multiple Sclerosis Patients.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis.
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
[Pediatric multiple sclerosis].
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics.
Refining a Web-based goal assessment interview: item reduction based on reliability and predictive validity.
White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses.
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
[Capabilities of positron emission tomography to study mecha-nisms of multiple sclerosis: own data and literature].
Early and Extensive Spinal White Matter Involvement in Neuromyelitis Optica.
Cancer drug shows promise for multiple sclerosis.
Pages
« first
‹ previous
…
608
609
610
611
612
613
614
615
616
…
next ›
last »